Does Vertex (VERX) Demonstrate Favorable Long-Term Trend?

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the ...
India West

Vertex, CRISPR Therapeutics Land On TIME’s Most Influential Companies List

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...
pharmaphorum

Vertex buys diabetes cell therapy rival ViaCyte for $320m

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...
pharmaphorum

Vertex gets EU okay to treat younger cystic fibrosis patients

Vertex gets EU okay to treat younger cystic fibrosis patients A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis therapy Symkevi to children as young as six if they have ...

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...
U.S. News & World Report

Manhattan Center for Science and Mathematics

AO Advice: How Your High School is Evaluated in the College Admissions Process Get the inside scoop on how colleges assess your high school and its course rigor. Featuring a former Admissions Officer, ...